Should Cetuximab Replace Cisplatin for Definitive Chemoradiotherapy in Locally Advanced Head and Neck Cancer?

被引：20
作者：
Riaz, Nadeem [1 ]
Sherman, Eric J. [1 ]
Fury, Matthew [1 ]
Lee, Nancy [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 02期
关键词：
SQUAMOUS-CELL CARCINOMA; RADIOTHERAPY; CHEMOTHERAPY; COMBINATION; EFFICACY;
D O I：
10.1200/JCO.2012.46.9049
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：287 / 288
页数：2
相关论文
共 17 条
[1]  
Ang KK, 2011, J CLIN ONCOL S, V29, p360s
[2]  
[Anonymous], MULT HEAD NECK CANC
[3]   Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck [J].
Bonner, JA ;
Harari, PM ;
Giralt, J ;
Azarnia, N ;
Shin, DM ;
Cohen, RB ;
Jones, CU ;
Sur, R ;
Raben, D ;
Jassem, J ;
Ove, R ;
Kies, MS ;
Baselga, J ;
Youssoufian, H ;
Amellal, N ;
Rowinsky, EK ;
Ang, KK .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (06) :567-578
[4]   Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival [J].
Bonner, James A. ;
Harari, Paul M. ;
Giralt, Jordi ;
Cohen, Roger B. ;
Jones, Christopher U. ;
Sur, Ranjan K. ;
Raben, David ;
Baselga, Jose ;
Spencer, Sharon A. ;
Zhu, Junming ;
Youssoufian, Hagop ;
Rowinsky, Eric K. ;
Ang, K. Kian .
LANCET ONCOLOGY, 2010, 11 (01) :21-28
[5]   Locoregionally advanced head and neck cancer treated with primary radiotherapy: A comparison of the addition of cetuximab or chemotherapy and the impact of protocol treatment [J].
Caudell, Jimmy J. ;
Sawrie, Stephen M. ;
Spencer, Sharon A. ;
Desmond, Renee A. ;
Carroll, William R. ;
Peters, Glenn E. ;
Nabell, Lisle M. ;
Meredith, Ruby F. ;
Bonner, James A. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 71 (03) :676-681
[6]   Response of some head and neck cancers to epidermal growth factor receptor tyrosine kinase inhibitors may be linked to mutation of ERBB2 rather than EGFR [J].
Cohen, EEW ;
Lingen, MW ;
Martin, LE ;
Harris, PL ;
Brannigan, BW ;
Haserlat, SM ;
Okimoto, RA ;
Sgroi, DC ;
Dahiya, S ;
Muir, B ;
Clark, JR ;
Rocco, JW ;
Vokes, EE ;
Haber, DA ;
Bell, DW .
CLINICAL CANCER RESEARCH, 2005, 11 (22) :8105-8108
[7]   Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximab [J].
Curran, Desmond ;
Giralt, Jordi ;
Harari, Paul M. ;
Ang, K. Kian ;
Cohen, Rogr B. ;
Kies, Merrill S. ;
Jassem, Jacck ;
Baselga, Jose ;
Rowinsky, Eric K. ;
Amellal, Nadia ;
Comte, Sylvie ;
Bonner, James A. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (16) :2191-2197
[8]   CONCURRENT CISPLATIN AND RADIATION VERSUS CETUXIMAB AND RADIATION FOR LOCALLY ADVANCED HEAD-AND-NECK CANCER [J].
Koutcher, Lawrence ;
Sherman, Eric ;
Fury, Matthew ;
Wolden, Suzanne ;
Zhang, Zhigang ;
Mo, Qianxing ;
Stewart, Laschelle ;
Schupak, Karen ;
Gelblum, Daphna ;
Wong, Richard ;
Kraus, Dennis ;
Shah, Jatin ;
Zelefsky, Michael ;
Pfister, David ;
Lee, Nancy .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (04) :915-922
[9]  
Koutcher LD, 2010, AM SOC RAD ONC ANN M
[10]  
Lefebvre J, 2012, J CLIN ONCOL S15, V30, p360s
12